CAPRICOR THERAPEUTICS, INC. (CAPR) › Cash & EquivalentsCAPRICOR THERAPEUTICS, INC. (CAPR) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2005: $02009: $3.18M2010: $3.38M2011: $1.55M2012: $170.1K2013: $1.73M2014: $8.03M2015: $5.57M2016: $3.20M2017: $6.14M2018: $4.26M2019: $3.90M2020: $32.67M2021: $34.89M2022: $9.60M2023: $14.69M2024: $11.29M2025: $287.85M$287.85M2005Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$287.85M+2450.3%2024$11.29M-23.2%2023$14.69M+53.0%2022$9.60M-72.5%2021$34.89M+6.8%2020$32.67M+737.7%2019$3.90M-8.5%2018$4.26M-30.6%2017$6.14M+91.6%2016$3.20M-42.5%2015$5.57M-30.7%2014$8.03M+364.6%2013$1.73M+916.7%2012$170.1K-89.0%2011$1.55M-54.1%2010$3.38M+6.4%2009$3.18M—2005$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share